A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis is a research paper published in Cancer Cell (2025). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Columbia University
Grant: P30DK132710
NCI NIH HHS
Grant: R35 CA210088
NIH NCI
Grant: P30CA013696
NCI NIH HHS
Grant: T32 CA285274
US Department of Defense
Grant: W81XWH-21-10901
Tonix Pharmaceuticals
Grant: CU21-3958
NIH NCI
Grant: R01CA272901
National Center for Advancing Translational Sciences
Grant: UL1TR001873
NIDDK NIH HHS
Grant: T32 DK007647
National Institutes of Health
DeGregorio Family Foundation
National Institute of Diabetes and Digestive and Kidney Diseases
FWCI
10.29
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals